A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology
Interventions: DRUG: BKM120
Sponsor: Novartis Pharmaceuticals